期刊文献+

初发2型糖尿病患者餐后胰高糖素样肽-1分泌模式 被引量:1

Postprandial Secretion Patterns of Glucagon-like Peptide-1 in Patients with Newly Diagnosed Type 2 Diabetes
下载PDF
导出
摘要 目的研究初发2型糖尿病患者馒头餐试验后胰高糖素样肽-1(GLP-1)的分泌情况。方法选择30例初发2型糖尿病患者(糖尿病组)和10名健康志愿者(对照组),行馒头餐试验。均于空腹,餐后30、60、120和180min静脉取血测定血糖、血浆胰岛素和GLP-1(7-36)。结果糖尿病组馒头餐试验后胰岛素水平及GLP-1水平均低于对照组(P<0.05)。结论初发2型糖尿病患者馒头餐试验后GLP-1水平降低。 Objective To investigate the secretion patterns of glucagon-like peptide-1 (GLP 1) after standard breakfast in patients with newly diagnosed type 2 diabetes. Methods A standard test meal (steamed bread prepared by 100 g of flour) was given to 30 patients with newly diagnosed type 2 diabetes and 10 healthy subjects. Venous blood was drawn before and 30, 60, 120 and 180 minutes after food intake for blood glucose,insulin and GLP-1(7-36) concentrations. Results After the test meal consumption,the levels of plasma insulin and GLP-1(7-36) amide in patients with newly diagnosed type 2 diabetes were lower than those in healthy subjects(P〈0.05). Conclusion Postprandial GLP-1 response is decreased in patients with newly diagnosed type 2 diabetes.
出处 《南昌大学学报(医学版)》 CAS 2011年第11期50-52,共3页 Journal of Nanchang University:Medical Sciences
关键词 2型糖尿病 初发 馒头餐试验 胰高糖素样肽-1 type 2 diabetes,newly diagnosed standard meal test glucagon-like peptide-1
  • 相关文献

参考文献4

二级参考文献75

  • 1Moore B,Edie ES,Abram JH.On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane.Biochem J,1906,1:28-38.
  • 2Zunz E,La Barre J.Contributions a letude des variations physiologiques de la seretion inteme du pancreas:relations entre les seretions exteme et interne di pancreas.Arch Int Physiol,1929,31:20-44.
  • 3Elrick H,Stimmler L,Hlad CJ,et al.Plasma insulin response to oral and intravenous glucose administration.J ClinEndocrinol Metab,1964,24:1076-1082.
  • 4Ding WG,Gromada J.Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.Diabetes,1997,46:615-621.
  • 5Bollag RJ,Zhong Q,Ding KH,et al.Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects.Mol Cell Endocrinol,2001,177:35-41.
  • 6Nauck MA,Bartels E,Orskov C,et al.Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1[7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretionin normal human subjects.Digestion,1992,52:214-221.
  • 7Salehi M,Aulinger BA,D'Alessio DA.Targeting β-cell mass in type 2 diabetes:promise and limitations of new drugs based on incretins.Endocr Rev,2008,29:367-379.
  • 8Holz GG,Kuhtreiber WM,Habener JF.Pancreatic β-cells are rendered glucose-competent by the insulinotropic hormone glucagonlike peptide-1 (7-37).Nature,1993,361:362-365.
  • 9Gromada J,Bokvist K,Ding WG,et al.Glucagon-like peptide 1(7-36) amide stimulates exocytosis in human pancreatic β-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.Diabetes,1998,47:57-65.
  • 10Knop FK.Reduced incretin effect in type 2 diabetes:cause or consequence of the diabetic state? Diabetes,2007,56:1951-1959.

共引文献34

同被引文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部